Related references
Note: Only part of the references are listed.Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial
Whitney Wharton et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial
Patrick G. Kehoe et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease
Sultan Chaudhury et al.
NEUROBIOLOGY OF AGING (2018)
Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology
Patrick Gavin Kehoe et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases
Janou A. Y. Roubroeks et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease
Valentina Escott-Price et al.
NEUROBIOLOGY OF AGING (2017)
Memory is preserved in older adults taking AT1 receptor blockers
Jean K. Ho et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Small vessel disease, neurovascular regulation and cognitive impairment: post-mortem studies reveal a complex relationship, still poorly understood
Seth Love et al.
CLINICAL SCIENCE (2017)
Polygenic Risk Score Analysis of Pathologically Confirmed Alzheimer Disease
Escott-Price Valentina et al.
ANNALS OF NEUROLOGY (2017)
Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides
Laibaik Park et al.
CIRCULATION RESEARCH (2017)
Drug candidates in clinical trials for Alzheimer's disease
Shih-Ya Hung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Cerebrovascular disease in ageing and Alzheimer's disease
Seth Love et al.
ACTA NEUROPATHOLOGICA (2016)
Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence
Abdelrahman Y. Fouda et al.
CLINICAL SCIENCE (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Dementia in western Europe: epidemiological evidence and implications for policy making
Yu-Tzu Wu et al.
LANCET NEUROLOGY (2016)
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis
Y. Iturria-Medina et al.
NATURE COMMUNICATIONS (2016)
Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology
Patrick Gavin Kehoe et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
The Intrarenal Renin-Angiotensin System in Hypertension
Robert M. Carey
ADVANCES IN CHRONIC KIDNEY DISEASE (2015)
Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease
Whitney Wharton et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
Axel Montagne et al.
NEURON (2015)
A Systems Approach to Drug Discovery in Alzheimer's Disease
Michael Shelanski et al.
NEUROTHERAPEUTICS (2015)
Association Between Angiotensin Receptor Blockers and Longitudinal Decline in Tau in Mild Cognitive Impairment
Ihab Hajjar et al.
JAMA NEUROLOGY (2015)
The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives
Russell H. Swerdlow et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors
Ross G. Douglas et al.
CLINICAL SCIENCE (2014)
Pharmacokinetic evaluation of lisinopril-tryptophan, a novel C-domain ACE inhibitor
Paolo Denti et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Renin Angiotensin Aldosterone System Inhibition in Controlling Dementia-Related Cognitive Decline
Ronan O'Caoimha et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Effects of Centrally Acting Angiotensin Converting Enzyme Inhibitors on Functional Decline in Patients with Alzheimer's Disease
Ronan O'Caoimh et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
The N-terminal Region of Amyloid β Controls the Aggregation Rate and Fibril Stability at Low pH Through a Gain of Function Mechanism
Kristoffer Brannstrom et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease
Hadassa M. Jochemsen et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
ACE for all - a molecular perspective
Charlotte Harrison et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2014)
Modulation of Renin-Angiotensin System and Arterial Stiffness: Evidence from Clinical Trials
Il Suk Sohn et al.
CURRENT HYPERTENSION REVIEWS (2014)
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
Patrick L. McGeer et al.
ACTA NEUROPATHOLOGICA (2013)
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging
Vincenzo Solfrizzi et al.
AGE (2013)
Aβ43 Is the Earliest-Depositing Aβ Species in APP Transgenic Mouse Brain and Is Converted to Aβ41 by Two Active Domains of ACE
Kun Zou et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease
Emma Louise Ashby et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Lack of Specificity of Commercial Antibodies Leads to Misidentification of Angiotensin Type 1 Receptor Protein
Marcela Herrera et al.
HYPERTENSION (2013)
Associations of Angiotensin Targeting Antihypertensive Drugs with Mortality and Hospitalization in Primary Care Patients with Dementia
Patrick Gavin Kehoe et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Antihypertensive Therapy and Cerebral Hemodynamics in Executive Mild Cognitive Impairment: Results of a Pilot Randomized Clinical Trial
Ihab Hajar et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2013)
C domain-selective inhibition of angiotensin-converting enzyme
Mario R. Ehlers et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Antihypertensive drugs decrease risk of Alzheimer disease Ginkgo Evaluation of Memory Study
Sevil Yasar et al.
NEUROLOGY (2013)
N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody
Gregory Antonios et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series
Ihab Hajjar et al.
ARCHIVES OF NEUROLOGY (2012)
Diagnosed hypertension in Canada: incidence, prevalence and associated mortality
Cynthia Robitaille et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
Six Commercially Available Angiotensin II AT1 Receptor Antibodies are Non-specific
Julius Benicky et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Angiotensin-Converting Enzyme and Progression of White Matter Lesions and Brain Atrophy - The SMART-MR Study
Hadassa M. Jochemsen et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
The Renin-Angiotensin System and Antihypertensive Drugs in Alzheimer's Disease: Current Standing of the Angiotensin Hypothesis?
Patrick G. Kehoe et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Drug repositioning for Alzheimer's disease
Anne Corbett et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease
Benjamin W. Miller et al.
ANNALS OF PHARMACOTHERAPY (2011)
Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment
Philine Schneider et al.
BIOLOGICAL PSYCHIATRY (2011)
Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease
Sathish Kumar et al.
EMBO JOURNAL (2011)
Angiotensin II Binding to Angiotensin I-Converting Enzyme Triggers Calcium Signaling
Paola B. Guimaraes et al.
HYPERTENSION (2011)
Placebo-Controlled Trials of Blood Pressure-Lowering Therapies for Primary Prevention of Dementia
Jan A. Staessen et al.
HYPERTENSION (2011)
Associations of Anti-Hypertensive Treatments with Alzheimer's Disease, Vascular Dementia, and Other Dementias
Neil M. Davies et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease
James Scott Miners et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Resolving controversies on the path to Alzheimer's therapeutics
Dennis J. Selkoe
NATURE MEDICINE (2011)
Calcium Signalling and Alzheimer's Disease
Michael J. Berridge
NEUROCHEMICAL RESEARCH (2011)
Central Angiotensin II Stimulation Promotes β Amyloid Production in Sprague Dawley Rats
Donglin Zhu et al.
PLOS ONE (2011)
Brain renin-angiotensin-A new look at an old system
John W. Wright et al.
PROGRESS IN NEUROBIOLOGY (2011)
Angiotensin-Converting Enzyme as a Potential Target for Treatment of Alzheimer's Disease: Inhibition or Activation?
Kun Zou et al.
REVIEWS IN THE NEUROSCIENCES (2011)
Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease
Koji Yamada et al.
BRAIN RESEARCH (2010)
Strain differences in the effects of Angiotensin IV on mouse cognition
Bruno J. D. Golding et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Type 2 Diabetes and Related Conditions in Relation to Dementia: An Opportunity for Prevention?
Jose A. Luchsinger
JOURNAL OF ALZHEIMERS DISEASE (2010)
The N Domain of Human Angiotensin-I-converting Enzyme THE ROLE OF N-GLYCOSYLATION AND THE CRYSTAL STRUCTURE IN COMPLEX WITH AN N DOMAIN-SPECIFIC PHOSPHINIC INHIBITOR, RXP407
Colin S. Anthony et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Vascular Hypothesis of Alzheimer's Disease: Bench to Bedside and Beyond
Jack C. de la Torre
NEURODEGENERATIVE DISEASES (2010)
Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
Lusine Danielyan et al.
REJUVENATION RESEARCH (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
The Neuropathology of Probable Alzheimer Disease and Mild Cognitive Impairment
Julie A. Schneider et al.
ANNALS OF NEUROLOGY (2009)
Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension Results From the Cardiovascular Health Study
Kaycee M. Sink et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Candesartan improves memory decline in mice: Involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin
Santoshkumar Tota et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Antagonist of peroxisome proliferator-activated receptor γ induces cerebellar amyloid-β levels and motor dysfunction in APP/PS1 transgenic mice
Jing Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors
Albert Fournier et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Continuous Activation of Renin-Angiotensin System Impairs Cognitive Function in Renin/Angiotensinogen Transgenic Mice
Shinji Inaba et al.
HYPERTENSION (2009)
Angiotensin Receptor Blocker Prevented β-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling
Shuko Takeda et al.
HYPERTENSION (2009)
Aβ42-to-Aβ40-and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
Kun Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
IRAP and AT(1) receptor mediated effects of angiotensin IV
A. G. Dupont et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta
John S. K. Kauwe et al.
NEUROGENETICS (2009)
Assessment of Alzheimer's disease case-control associations using family-based methods
Brit-Maren M. Schjeide et al.
NEUROGENETICS (2009)
Duration of antihypertensive drug use and risk of dementia A prospective cohort study
M. D. M. Haag et al.
NEUROLOGY (2009)
Angiotensins in Alzheimer's disease - friend or foe?
Patrick G. Kehoe et al.
TRENDS IN NEUROSCIENCES (2009)
Pathophysiology of vascular dementia
Francesco Iemolo et al.
Immunity & Ageing (2009)
O1-05-05: Use of angiotensin receptor blockers is associated with a lower incidence and progression of Alzheimer's disease
Benjamin Wolozin et al.
Alzheimers & Dementia (2008)
Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: An observational study
Ihab M. Hajjar et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2008)
Effects of Cardiovascular Medications on Rate of Functional Decline in Alzheimer Disease
P. B. Rosenberg et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease
Luca Rozzini et al.
ARCHIVES OF NEUROLOGY (2008)
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease
Hao Li et al.
ARCHIVES OF NEUROLOGY (2008)
Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study Implication of Additional Loci
Joseph H. Lee et al.
ARCHIVES OF NEUROLOGY (2008)
Telmisartan prevented cognitive decline partly due to PPAR-γ activation
Masaki Mogi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase
Siew Yeen Chai et al.
BMC NEUROSCIENCE (2008)
Cognitive-enhancing effects of angiotensin IV
Paul R. Gard
BMC NEUROSCIENCE (2008)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer's disease amyloid β(1-16) peptide
Philipp O. Tsvetkov et al.
CHEMBIOCHEM (2008)
The role of the cell surface LRP and soluble LRP in blood-brain barrier a clearance in Alzheimer's Disease
R. Deane et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-β peptides
Xiaoou Sun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase
Anthony L. Albiston et al.
FASEB JOURNAL (2008)
Confronting complexity in late-onset Alzheimer disease: Application of two-stage analysis approach addressing heterogeneity and epistasis
Tricia A. Thornton-Wells et al.
GENETIC EPIDEMIOLOGY (2008)
Epidemiology of stroke and high blood pressure in Africa
G. A. Mensah
HEART (2008)
Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo
Sebastien Fuchs et al.
HYPERTENSION (2008)
Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype
Joep H. M. van Esch et al.
JOURNAL OF HYPERTENSION (2008)
Renin-angiotensin system revisited
F. Fyhrquist et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Brain renin angiotensin in disease
M. Ian Phillips et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
Ruth Peters et al.
LANCET NEUROLOGY (2008)
Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease
Magdolna Paskaski et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy
J. S. Miners et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats
D. Kumaran et al.
NEUROSCIENCE (2008)
Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein
Laibaik Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's A beta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Ilya Yu. Toropygin et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease
Roy O. Weller et al.
BRAIN PATHOLOGY (2008)
Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease
Jun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Angiotensin II controls occludin function and is required for blood-brain barrier maintenance: Relevance to multiple sclerosis
Karolina Wosik et al.
JOURNAL OF NEUROSCIENCE (2007)
Angiotensin-converting enzyme converts amyloid β-protein 1-42 (Aβ1-42) to Aβ1-40, and its inhibition enhances brain aβ deposition
Kun Zou et al.
JOURNAL OF NEUROSCIENCE (2007)
Soluble adhesion molecules and angiotensin-converting enzyme in dementia
Henrietta M. Nielsen et al.
NEUROBIOLOGY OF DISEASE (2007)
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Patrick G. Kehoe et al.
LANCET NEUROLOGY (2007)
A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease
Keith D. Coon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Angiotensin II receptor blockers for the treatment of heart failure: A class effect?
Marie Hudson et al.
PHARMACOTHERAPY (2007)
Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease
Matthew L. Hemming et al.
NEUROBIOLOGY OF DISEASE (2007)
The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration
J. Ellul et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Lars Bertram et al.
NATURE GENETICS (2007)
Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain
Jan A. Staessen et al.
HYPERTENSION (2007)
Diabetes mellitus and risk of developing Alzheimer disease - Results from the Framingham study
Abimbola Akomolafe et al.
ARCHIVES OF NEUROLOGY (2006)
Regulation of steady-state β-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme
Elizabeth A. Eckman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme
Aloysius T. Nchinda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment
Luca Rozzini et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Association of Polymorphisms in the angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community
Y Meng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Antihypertensive medication use and incident Alzheimer disease - The Cache County Study
Ara S. Khachaturian et al.
ARCHIVES OF NEUROLOGY (2006)
Regulation of peroxisome proliferator-activated receptor γ activity by losartan metabolites
M Schupp et al.
HYPERTENSION (2006)
Update on hypertension and Alzheimer's disease
Ingmar Skoog et al.
NEUROLOGICAL RESEARCH (2006)
Molecular activation of PPAR gamma by angiotensin II type 1-receptor antagonists
David V. Erbe et al.
VASCULAR PHARMACOLOGY (2006)
Peroxisomal proliferation protects from β-amyloid neurodegeneration
MJ Santos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Angiotensin peptides and their pleiotropic actions
I Haulica et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2005)
Amyloid β-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor
ML Hemming et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss
O Hanon et al.
STROKE (2005)
Effect of baseline cognitive function and anti hypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)
I Skoog et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala
K Sleegers et al.
NEUROBIOLOGY OF AGING (2005)
Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas
K Hellner et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2005)
Neurovascular mechanisms of Alzheimer's neurodegeneration
BV Zlokovic
TRENDS IN NEUROSCIENCES (2005)
Role of angiotensin III in hypertension
A Reaux-Le Goazigo et al.
CURRENT HYPERTENSION REPORTS (2005)
Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?
V Feigin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats
JH Tan et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide
R Oba et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population
L Hajjar et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2005)
Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan
T Ohrui et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease
PG Kehoe et al.
HUMAN GENETICS (2004)
Alzheimer disease risk and genetic variation in ACE - A meta-analysis
JS Elkins et al.
NEUROLOGY (2004)
Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension
R Fogari et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart
HS Lim et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist
N Lochard et al.
CIRCULATION RESEARCH (2004)
A genetic variant of ACE increases cell survival: a new paradigm for biology and disease
HK Hamdi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Stroke and the risk of Alzheimer disease
LS Honig et al.
ARCHIVES OF NEUROLOGY (2003)
Influence of losartan and atenolol on memory function in very elderly hypertensive patients
R Fogari et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme
PV Binevski et al.
FEBS LETTERS (2003)
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
RAS Santos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inflammation and angiotensin II
Y Suzuki et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
The Study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial
H Lithell et al.
JOURNAL OF HYPERTENSION (2003)
Haplotypes extending across ACE are associated with Alzheimer's disease
PG Kehoe et al.
HUMAN MOLECULAR GENETICS (2003)
Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats
SM Manschot et al.
BRAIN RESEARCH (2003)
Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease
T Shimizu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides
R Cox et al.
HUMAN MOLECULAR GENETICS (2002)
The prevention of dementia with antihypertensive treatment
F Forette et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity
F Soubrier et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2002)
Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ);: Retards Aβ aggregation, deposition, fibril formation, and inhibits cytotoxicity.
JG Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia
E Savaskan et al.
NEUROBIOLOGY OF AGING (2001)
Midlife vascular risk factors and Alzheimer's disease in later life:: longitudinal, population based study
M Kivipelto et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Chronic effects of ACE-inhibition (quinapril) and angiotensin-II type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction
K Hu et al.
BASIC RESEARCH IN CARDIOLOGY (2001)
The ACE gene and Alzheimer's disease susceptibility
Y Narain et al.
JOURNAL OF MEDICAL GENETICS (2000)
Midlife blood pressure and dementia: the Honolulu-Asia aging study
LJ Launer et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
